Flagship Ventures Fund Iv General Partner Llc - Net Worth and Insider Trading

Over the past 18 months, Flagship Ventures Fund Iv General Partner Llc made no insider transaction in Moderna Inc (MRNA). Other recent insider transactions involving Moderna Inc (MRNA) include a net sale of 580,000 shares made by Noubar Afeyan , a net sale of 2,523,506 shares made by Stephane Bancel , and a net sale of 170,786 shares made by Stephen Hoge .

In summary, during the past 3 months, insiders sold 222,273 shares of Moderna Inc (MRNA) in total and bought 0 shares, with a net sale of 222,273 shares. During the past 18 months, 3,301,245 shares of Moderna Inc (MRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,301,245 shares.

Moderna Inc (MRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures Fund Iv General Partner Llc made no insider transaction in Evelo Biosciences Inc (EVLO). Other recent insider transactions involving Evelo Biosciences Inc (EVLO) include a net sale of 103,730 shares made by Mark Bodmer , a net sale of 80,121 shares made by Duncan Mchale , and a net sale of 46,345 shares made by Marella Thorell .

In summary, during the past 3 months, insiders sold 0 shares of Evelo Biosciences Inc (EVLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 46,837 shares of Evelo Biosciences Inc (EVLO) were sold and 5,411,255 shares were bought by its insiders, resulting in a net purchase of 5,364,418 shares.

Evelo Biosciences Inc (EVLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Kaleido Biosciences Inc (KLDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kaleido Biosciences Inc (KLDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kaleido Biosciences Inc (KLDO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures Fund Iv General Partner Llc made no insider transaction in Axcella Health Inc (AXLA). Other recent insider transactions involving Axcella Health Inc (AXLA) include a net sale of 5,221 shares made by Paul Fehlner ,

In summary, during the past 3 months, insiders sold 0 shares of Axcella Health Inc (AXLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 209 shares of Axcella Health Inc (AXLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 209 shares.

Axcella Health Inc (AXLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures Fund Iv General Partner Llc made no insider transaction in TransMedics Group Inc (TMDX). Other recent insider transactions involving TransMedics Group Inc (TMDX) include a net sale of 249,446 shares made by Tamer I Khayal , a net sale of 271,427 shares made by Waleed H Hassanein , and a net sale of 96,903 shares made by Stephen Gordon .

In summary, during the past 3 months, insiders sold 344,297 shares of TransMedics Group Inc (TMDX) in total and bought 0 shares, with a net sale of 344,297 shares. During the past 18 months, 762,263 shares of TransMedics Group Inc (TMDX) were sold and 2,500 shares were bought by its insiders, resulting in a net sale of 759,763 shares.

TransMedics Group Inc (TMDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures Fund Iv General Partner Llc made no insider transaction in Rubius Therapeutics Inc (RUBY). Other recent insider transactions involving Rubius Therapeutics Inc (RUBY) include a net sale of 15,688 shares made by Pablo J Cagnoni , a net sale of 14,263 shares made by Dannielle Appelhans , and a net sale of 2,593 shares made by Laurence A. Turka .

In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,544 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 32,544 shares.

Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures Fund Iv General Partner Llc made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net sale of 689 shares made by Eric R Olson .

In summary, during the past 3 months, insiders sold 10,601 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 10,601 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 904,977 shares were bought by its insiders, resulting in a net purchase of 873,765 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures Fund Iv General Partner Llc made no insider transaction in Sesen Bio Inc (SESN). Other recent insider transactions involving Sesen Bio Inc (SESN) include a net sale of 541,214 shares made by Thomas R Cannell , a net sale of 407,711 shares made by Monica Forbes , and a net sale of 259,049 shares made by Mark Sullivan .

In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 71,436 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 71,436 shares.

Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures Fund Iv General Partner Llc made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 6,647 shares made by Bruce Eaton , a net sale of 7,365 shares made by Michelle Robertson , and a net sale of 84,310 shares made by Gilmore Neil O'neill .

In summary, during the past 3 months, insiders sold 98,151 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 98,151 shares. During the past 18 months, 125,756 shares of Editas Medicine Inc (EDIT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 125,756 shares.

Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures Fund Iv General Partner Llc made no insider transaction in Seres Therapeutics Inc (MCRB). Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 16,114 shares made by David S. Ege , a net sale of 20,101 shares made by Eric D. Shaff , and a net sale of 8,632 shares made by Moltke Lisa Von .

In summary, during the past 3 months, insiders sold 36,381 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 36,381 shares. During the past 18 months, 78,188 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 78,188 shares.

Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures Fund Iv General Partner Llc made no insider transaction in T2 Biosystems Inc (TTOO). Other recent insider transactions involving T2 Biosystems Inc (TTOO) include a net sale of 48,345,798 shares made by Cr Group L.p. , a net sale of 3,969 shares made by Michael Terrence Gibbs , and a net sale of 1,074 shares made by Brett A. Giffin .

In summary, during the past 3 months, insiders sold 0 shares of T2 Biosystems Inc (TTOO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 48,363,307 shares of T2 Biosystems Inc (TTOO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 48,363,307 shares.

T2 Biosystems Inc (TTOO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of CARISMA Therapeutics Inc (CARM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CARISMA Therapeutics Inc (CARM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CARISMA Therapeutics Inc (CARM)'s detailed insider trading history can be found in Insider Trading Tracker table.